基于wnt5a介导的信号通路间crosstalk研究参芪延肾方下调肾性骨病高转换骨代谢的机制
批准号:
82074256
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
王琴
依托单位:
学科分类:
中西医结合临床基础
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
王琴
中文摘要
积极治疗肾性骨病(ROD),能降低慢性肾病(CKD)患者骨折和心血管疾病发生率,提升患者生活质量,延长生存年限。基于“肾主骨”理论从肾论治,为治疗ROD提供了重要思路。参芪延肾方是治疗CKD的有效组方,前期研究发现其改善CKD动物模型高转换ROD病理状态,降低骨组织中Wnt5a阳性表达。结合Wnt5a介导非经典Wnt通路及经典Wnt通路间crosstalk,影响成骨细胞、破骨细胞分化和功能活性的研究进展,课题组提出假说:“参芪延肾方通过干预Wnt5a介导的信号通路间crosstalk,抑制成骨细胞、破骨细胞分化和功能活性,下调ROD高转换型骨代谢。”拟采用动物模型与细胞培养,从动物-细胞-分子水平探讨参芪延肾方下调ROD高转换骨代谢的机制,并应用基因敲除、干扰和过表达等手段验证。研究将丰富“肾主骨”理论科学内涵,为临床治疗高转换ROD提供新的靶点与途径,有助于发掘治疗肾性骨病的中药新药。
英文摘要
Renal osteodystrophy (ROD) is independently associated with mortality and morbidity associated with fracture and cardiovascular complications in patients with chronic kidney disease (CKD). Based on the TCM theory, the traditional Chinese medicine (TCM) exhibited effects on improving bone metabolism through nourishing kidney, would be provided as a potential therapeutic method for ROD. Shenqi yanshen formula (SQYSF) ameliorate kidney injury in patients with CKD. In our previous study, SQYSF decreased the high turnover bone disease induced by different rat models with CKD, as well as Wnt5a expression. It has been reported that Wnt5a play a critical role in the differentiation of osteoblast and osteoclast and the bone function in formation and absorption. In view of this, we make the hypotheses that SQYSF depress the high turnover bone disease in CKD by inactivating the crosstalk among canonical Wnt signaling pathway and non-canonical Wnt signaling pathways, and then inhibiting the differentiation of osteoblast and osteoclast and the bone function in formation and absorption. In this study, a rat model with CKD given a special diet with high phosphorus and low calcium to further induce high turnover bone disease, and cells including bone marrow mesenchymal cell, bone marrow macrophages, osteoblast and osteoclast, will be used to explore the molecular mechanism. Moreover, osteoblast-lineage cell-specific Wnt5a-deficient mice (Wnt5a cKO), siRNA Wnt5a and Wnt5a overexpression mediated by adenovirus would be used to further prove our hypotheses. The results would be benefit to explain the TCM theory and enrich its scientific connotation, and helpful to explore potential therapeutic targets and provide promising medicine for ROD treatment.
肾性骨病(ROD)是慢性肾脏病(CKD)的常见并发症,其引发的矿物质代谢紊乱,是导致骨折相关疾病和心血管疾病发病率和死亡率增加的独立危险因素,严重影响患者生活质量与生存年限。基于“肾主骨”中医理论从肾论治,为中医药治疗ROD提供了重要思路。参芪延肾方是我院国医大师郑新教授依据CKD3~5期患者病机总结出的临床有效方药,前期研究发现:参芪延肾方改善CKD患者肾功能及中医症候积分,缓解ROD模型动物高转换骨病病理状态,但生物学机制尚不明确。.课题组首先制备高转化型ROD动物模型,并明确参芪延肾方对该模型的药效学作用,以及对Wnt5a介导的影响成骨细胞、破骨细胞分化和功能活性的信号通路的调控作用;然后,采用条件性敲除成骨细胞Wnt5a基因小鼠(Wnt5af/f OCN-Cre)、骨髓间充质干细胞(BMSC)、成骨细胞(MC3T3-E1)、骨髓巨噬细胞(RAW.264.7),通过体内外实验研究,并验证参芪延肾方通过Wnt5a介导调控成骨细胞、破骨细胞分化和功能活性的信号通路间crosstalk,下调高转换肾性骨病活性状态的科学假说。结果表明,参芪延肾方通过Wnt5a-OSX-Lrp5/6、Wnt3a-Lrp5/6-Rankl调控MC3T3-E1、BMSC的成骨分化和骨形成;通过Wnt5a-Rho-Pkn3调控RAW.264.7的破骨分化及骨吸收;在MC3T3-E1细胞与BMSC细胞的共培体系中,参芪延肾方通过成骨细胞Wnt5a促进BMSC细胞成骨分化,而沉默MC3T3-E1细胞Wnt5a抑制了参芪延肾方的促BMSC细胞成骨分化作用,且BMSC细胞的Wnt3a-Lrp5/6-Rankl信号通路被抑制。提示,成骨细胞源Wnt5a对成骨细胞、骨髓间充质干细胞的成骨分化及骨形成至关重要。与肾性骨病Wnt5af/f OCN-Cre小鼠模型组相比,参芪延肾方能改善肾性骨病Wnt5af/f OCN-Cre小鼠的体重和肾功能,减轻肾病理学损伤,但对股骨骨量和骨小梁数量的改善未见统计学差异。提示,成骨细胞Wnt5a是参芪延肾方发挥促骨形成作用从而缓解ROD的关键靶点。.项目在“肾主骨”中医理论的指导下,明确了参芪延肾方通过Wnt5a介导的信号通路及crosstalk改善ROD的作用机制,成骨细胞Wnt5a是参芪延肾方促骨形成的关键靶点,为研发治疗ROD的中药新药提供了实验依据。
基于调控Wnt/β-catenin/snail1信号通路阻抑EMT研究生地水提物抗肾纤维化机制
-
批准号:81603611
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:王琴
-
依托单位:
国内基金
海外基金